InNexus Biotechnology Inc.
The Mayo Clinic MCCRB Building
13208 East Shea Boulevard, Suite 200
Scottsdale
Arizona
85259
United States
Tel: 480-862-7500
Fax: 480-657-8919
Website: http://www.ixsbio.com/
Email: jmorhet@innexusbiotech.com
103 articles about InNexus Biotechnology Inc.
-
InNexus Biotechnology Inc. Appoints Chief Financial Officer
10/20/2011
-
InNexus Biotechnology Inc. Grants Incentive Stock Options
9/19/2011
-
InNexus Biotechnology Inc. Begins Joint Research Program - Receives Award for Antibody Technologies
7/14/2011
-
InNexus Biotechnology Inc. Files Patent for Novel AMD Therapeutic
6/15/2011
-
Annual Shareholders' Meeting of InNexus Biotechnology Inc.: Shareholders Approve All Resolutions
5/26/2011
-
InNexus Biotechnology Inc. Hires New Chief Financial Officer
5/11/2011
-
InNexus Biotechnology Inc. Announces Annual General Meeting to Be Held 24 May 2011
3/24/2011
-
InNexus Biotechnology Inc. Expands Team to Focus on Licensing and Partnering
3/16/2011
-
InNexus Biotechnology Inc. Expands Team to Focus on Licensing and Partnering
3/16/2011
-
InNexus Biotechnology Inc. Provides Summary of 2010 Accomplishments and 2011 Outlook
3/3/2011
-
InNexus Biotechnology Inc. Awarded Federal Grant
11/5/2010
-
InNexus Biotechnology Inc. Amends Collaborative Agreement with the National Cancer Institute
7/1/2010
-
InNexus Biotechnology Inc. Announces Discovery of Novel Protein for AMD Eye Disorder - Will Bypass Needles with Topical Application
6/29/2010
-
InNexus Biotechnology Inc. Signs Collaboration Agreement with the National Cancer Institute
5/27/2010
-
InNexus Biotechnology Inc. DXL(TM) Antibody Technology Causes Cancer Cell Death By Mechanisms Not Seen with Current Market-Leading Medications
3/23/2010
-
InNexus Biotechnology Inc. Develops New Psoriasis Product Based on Its Skin Permeating Antibody Technology
1/6/2010
-
InNexus Biotechnology Inc. And XERIS Announce Research Collaboration
12/10/2009
-
InNexus Biotechnology Inc. Issues a Shareholder Update
12/2/2009
-
InNexus Biotechnology Inc. Announces Business Development Initiative for DXL625
8/5/2009
-
Renowned Cancer Researcher Dan Von Hoff, M.D. Joins InNexus Biotechnology Inc. Scientific Board
7/16/2009